Filing metadata

Accession number
0001209191-21-044027
Form type
Form 4
Filer
Quince Therapeutics, Inc.
CIK
CIK 1662774
Filed
Jun 30, 2021
Reporting period
Jun 28, 2021
Description
Insider transaction

Explore SEC Filings Hub